Esperion Therapeutics reported $7.12M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4021M 259M
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Amarin AMRN:US $ 22.24M 8.4M
Amgen AMGN:US $ 1561M 157M
Biogen BIIB:US $ 753.9M 93.8M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Daiichi Sankyo 4568:JP Y 88830M 3109M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Halozyme Therapeutics HALO:US $ 15.92M 5.66M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
Intra Cellular Therapies ITCI:US $ 3.16M 0.62M
IONIS PHARMACEUT IONS:US $ 4.17M 1.94M
Merk MRK:US $ 5334M 1507M
Moderna Inc MRNA:US 1.02B 65M
Nektar Therapeutics NKTR:US $ 5.32M 0.85M
Pfizer PFE:US $ 10010M 399M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Puma Biotechnology PBYI:US $ 10.84M 1.05M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Seattle Genetics SGEN:US $ 87.63M 0.94M
United Therapeutics UTHR:US $ 25.9M 8.7M
Vanda Pharmaceuticals VNDA:US $ 5.66M 0.57M